# Neoadjuvant Study of In-situ REIC/Dkk-3 in Prostate Cancer

> **NCT01197209** · PHASE1 · WITHDRAWN · sponsor: **Momotaro-Gene Inc.**

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** Ad-REIC/Dkk-3

## Key facts

- **NCT ID:** NCT01197209
- **Lead sponsor:** Momotaro-Gene Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-09
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Suspended due to change in development plans and investigator
- **Last updated:** 2013-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01197209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01197209, "Neoadjuvant Study of In-situ REIC/Dkk-3 in Prostate Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01197209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*